Get started
Cogent Biosciences, Inc.Cogent Biosciences, Inc.Cogent Biosciences, Inc.

Cogent Biosciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

COGT chart

Key stats

Market capitalization
‪676.48 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.40USD
Net income
‪−192.41 M‬USD
Revenue
—
Shares float
‪87.22 M‬
Beta (1Y)
0.40

About Cogent Biosciences, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Andrew R. Robbins
Website
cogentbio.com
Headquarters
Waltham
Employees (FY)
164
Founded
2014
ISIN
US19240Q2012
FIGI
BBG007DHZQR7
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of COGT is 6.50 USD — it has decreased by 0.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cogent Biosciences, Inc. stocks are traded under the ticker COGT.
Cogent Biosciences, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Cogent Biosciences, Inc. has a max estimate of 26.00 USD and a min estimate of 8.00 USD.
COGT earnings for the last quarter are −0.64 USD whereas the estimation was −0.50 USD which accounts for −27.72% surprise. Estimated earnings for the next quarter are −0.55 USD. See more details about Cogent Biosciences, Inc. earnings.
Cogent Biosciences, Inc. revenue for the last quarter amounts to ‪312.00 K‬ USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪50.00 K‬ USD.
Yes, you can track Cogent Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, COGT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cogent Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
COGT reached its all-time high on Aug 7, 2018 with the price of 70.64 USD, and its all-time low was 1.18 USD and was reached on Apr 9, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 164.00 employees. See our rating of the largest employees — is Cogent Biosciences, Inc. on this list?